These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 30444777)

  • 1. Overcorrected Midface Advancement to Improve Airway Problems in Severe Pfeiffer Syndrome Types II and III.
    Kobayashi S; Fukawa T; Yasumura K; Yabuki Y; Satake T; Maegawa J
    J Craniofac Surg; 2019 Jan; 30(1):53-56. PubMed ID: 30444777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The assessment of midface distraction osteogenesis in treatment of upper airway obstruction.
    Xu H; Yu Z; Mu X
    J Craniofac Surg; 2009 Sep; 20 Suppl 2():1876-81. PubMed ID: 19816368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory outcome of midface advancement with distraction: a comparison between Le Fort III and frontofacial monobloc.
    Mathijssen I; Arnaud E; Marchac D; Mireau E; Morisseau-Durand MP; Guérin P; Renier D
    J Craniofac Surg; 2006 Jul; 17(4):642-4. PubMed ID: 16877907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Le Fort III external midface distraction: surgical outcomes and skeletal stability.
    Iannetti G; Ramieri V; Pagnoni M; Fadda MT; Cascone P
    J Craniofac Surg; 2012 May; 23(3):896-900. PubMed ID: 22565921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achieving differential facial changes with Le Fort III distraction osteogenesis: the use of nasal passenger grafts, cerclage hinges, and segmental movements.
    Hopper RA; Prucz RB; Iamphongsai S
    Plast Reconstr Surg; 2012 Dec; 130(6):1281-1288. PubMed ID: 22878478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upper airway changes in syndromic craniosynostosis patients following midface or monobloc advancement: correlation between volume changes and respiratory outcome.
    Nout E; Bannink N; Koudstaal MJ; Veenland JF; Joosten KF; Poublon RM; van der Wal KG; Mathijssen IM; Wolvius EB
    J Craniomaxillofac Surg; 2012 Apr; 40(3):209-14. PubMed ID: 21624836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalizing facial ratios in apert syndrome patients with Le Fort II midface distraction and simultaneous zygomatic repositioning.
    Hopper RA; Kapadia H; Morton T
    Plast Reconstr Surg; 2013 Jul; 132(1):129-140. PubMed ID: 23508053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Airway changes following Le Fort III distraction osteogenesis for syndromic craniosynostosis: a clinical and cephalometric study.
    Flores RL; Shetye PR; Zeitler D; Bernstein J; Wang E; Grayson BH; McCarthy JG
    Plast Reconstr Surg; 2009 Aug; 124(2):590-601. PubMed ID: 19644279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional computed tomographic evaluation of Le Fort III distraction osteogenesis with an external device in syndromic craniosynostosis.
    Wery MF; Nada RM; van der Meulen JJ; Wolvius EB; Ongkosuwito EM
    Br J Oral Maxillofac Surg; 2015 Mar; 53(3):285-91. PubMed ID: 25605236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined push-pull distraction for correction of syndromic midfacial hypoplasia.
    Schulten A; Lim AA; Bruun RA; Hayes C; Mulliken JB; Padwa BL
    J Oral Maxillofac Surg; 2006 Jan; 64(1):23-30. PubMed ID: 16360853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional airway changes after Le Fort III advancement in syndromic craniosynostosis patients.
    Nout E; Bouw FP; Veenland JF; Hop WCJ; van der Wal KGH; Mathijssen IMJ; Wolvius EB
    Plast Reconstr Surg; 2010 Aug; 126(2):564-571. PubMed ID: 20679838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous Le Fort I, II, and III osteotomies for correction of midface deficiency in Apert disease.
    Dai J; Wang X; Yu H; Cheng J; Yuan H; Gui H; Shen S; Shen G
    J Craniofac Surg; 2012 Sep; 23(5):1391-5. PubMed ID: 22948639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Le Fort III distraction osteogenesis in syndromal craniosynostosis.
    Meling TR; Hans-Erik H; Per S; Due-Tonnessen BJ
    J Craniofac Surg; 2006 Jan; 17(1):28-39. PubMed ID: 16432404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monobloc minus Le Fort II for single-stage treatment of the Apert phenotype.
    Paliga JT; Goldstein JA; Storm PB; Taylor JA
    J Craniofac Surg; 2013 Jul; 24(4):1380-2. PubMed ID: 24015416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mid-face distraction after LeFort III osteotomy in craniofacial dysmorphism].
    Weingart D; Roser M; Lantos P
    Mund Kiefer Gesichtschir; 2001 Jul; 5(4):221-6. PubMed ID: 11550604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monobloc Frontofacial or Le Fort III Distraction Osteogenesis in Syndromic Craniosynostosis: Three-Dimensional Evaluation of Treatment Outcome and the Need for Central Distraction.
    Hu CH; Wu CT; Ko EW; Chen PK
    J Craniofac Surg; 2017 Jul; 28(5):1344-1349. PubMed ID: 28538077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications in 54 frontofacial distraction procedures in patients with syndromic craniosynostosis.
    Goldstein JA; Paliga JT; Taylor JA; Bartlett SP
    J Craniofac Surg; 2015 Jan; 26(1):124-8. PubMed ID: 25569391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obstructive sleep apnea in children with syndromic craniosynostosis: long-term respiratory outcome of midface advancement.
    Bannink N; Nout E; Wolvius EB; Hoeve HL; Joosten KF; Mathijssen IM
    Int J Oral Maxillofac Surg; 2010 Feb; 39(2):115-21. PubMed ID: 20056390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional orthognathic surgery following Le Fort III and monobloc advancement.
    Nout E; Koudstaal MJ; Wolvius EB; Van der Wal KG
    Int J Oral Maxillofac Surg; 2011 Jul; 40(7):679-84. PubMed ID: 21398092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled central advancement of the midface after Le Fort III osteotomy by a 3-point skeletal anchorage.
    Roldán JC; Moralis A; Dendorfer S; Witte J; Reicheneder C
    J Craniofac Surg; 2011 Nov; 22(6):2384-6. PubMed ID: 22134287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.